In our investigation, we identified another regulatory pathway of RUNX1 in GBM, the RUNX1/PDIA5/CCAR1 pathway, and demonstrated its role in promoting the malignant progression of GBM both in vitro and in vivo by regulating the expression of PDIA5. This evidence concerns the gene RUNX1 and glioblastoma.